Skip to main content

Table 2 FDG SULmax and FLT SULmax values at all time points for each patient

From: A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB–IIIA resectable NSCLC

Patient number Baseline Post-cycle 1 Post-cycle 2
FDG FLT CT FDG FLT CT (%) FDG FLT CT (%)
1 9.3 3.4 6.5 8.8 6.8 3.1 4.1 2.2 −7.7
2* 12.7 5.2 7.4 3.4 1.7 −45.9 1.5 1.0 −56.8
3 3.2 2.3 2.4 4.0 1.0 4.2 3.3 1.1 −8.3
4 8.3 4.5 8.6 6.7 2.9 44.2 14.0 −16.3
5 14.0 4.6 5.4 14.6 4.4 31.5 7.4 3.9 −29.6
6* 10.9 4.9 5.9 8.9 4.2 −25.4 8.6 4.4 −52.5
7 5.5 2.7 2.1 7.7 2.9 0.0 5.4 2.5 −14.3
8 7.1 4.2 11.5 6.9 4.6 −23.5 6.7 5.3 −27.8
9* 8.4 2.1 8.4 4.8 1.8 −21.4 3.9 1.4 −44.0
  1. Post-cycle 1 and post-cycle 2 CT values are shown as percentage changes from baseline. Responders are denoted by an asterisk after the patient number